Mark E. Smolkin
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 26
- Immunotherapy and Immune Responses 26
- T-cell and B-cell Immunology 5
- Oncology 15
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Craig L. Slingluff (35 shared papers)Gina R. Petroni (35 shared papers)Kimberly A. Chianese‐Bullock (22 shared papers)James W. Patterson (7 shared papers)Donna H. Deacon (13 shared papers)Lynn T. Dengel (6 shared papers)William W. Grosh (15 shared papers)Gulsun Erdag (4 shared papers)
- Journals
- Cancer Immunology Immunotherapy (9 papers)Journal for ImmunoTherapy of Cancer (8 papers)Journal of Clinical Oncology (3 papers)Gynecologic Oncology (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesQatarNetherlands
In The Last Decade
Mark E. Smolkin
83 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 130
- Immunology 1.4k
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 386
- Cancer Research 175
- Molecular Biology 775
Countries citing papers authored by Mark E. Smolkin
This map shows the geographic impact of Mark E. Smolkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Smolkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Smolkin more than expected).
Fields of papers citing papers by Mark E. Smolkin
This network shows the impact of papers produced by Mark E. Smolkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Smolkin. The network helps show where Mark E. Smolkin may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Smolkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 461 | |
| 2 | 2007 | 145 | |
| 3 | 2009 | 140 | |
| 4 | 2011 | 105 | |
| 5 | 2016 | 104 | |
| 6 | 2008 | 98 | |
| 7 | 2016 | 96 | |
| 8 | 2006 | 94 | |
| 9 | 2004 | 92 | |
| 10 | 2008 | 84 | |
| 11 | 2006 | 83 | |
| 12 | 2019 | 77 | |
| 13 | 2012 | 73 | |
| 14 | 2004 | 72 | |
| 15 | 2011 | 69 | |
| 16 | 2009 | 61 | |
| 17 | 2012 | 58 | |
| 18 | 2012 | 54 | |
| 19 | 2017 | 52 | |
| 20 | 2019 | 51 |
About Mark E. Smolkin
Mark E. Smolkin is a scholar working on Immunology, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Surgery, having authored 87 papers that have together received 3.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (26 papers), Cancer Immunotherapy and Biomarkers (6 papers), T-cell and B-cell Immunology (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers), vaccines and immunoinformatics approaches (4 papers), Digital Radiography and Breast Imaging (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Brain Metastases and Treatment (3 papers). The work is most often cited by research in Immunology (1.4k citations), Oncology (1.3k citations), Pulmonary and Respiratory Medicine (386 citations), Cancer Research (175 citations) and Molecular Biology (775 citations). Mark E. Smolkin has collaborated with scholars based in United States, Qatar and Netherlands. Frequent co-authors include Craig L. Slingluff, Gina R. Petroni, Kimberly A. Chianese‐Bullock, James W. Patterson, Donna H. Deacon, Lynn T. Dengel, William W. Grosh, Gulsun Erdag, Walter C. Olson and Sofia M. Shea. Their work appears in journals such as Cancer Immunology Immunotherapy, Journal for ImmunoTherapy of Cancer, Journal of Clinical Oncology, Gynecologic Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.